2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT2-Selective Melatonin Receptor Antagonists

Journal of Medicinal Chemistry
2009.0

Abstract

A novel series of 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues has been prepared to probe the steric and electronic properties of the binding pocket of the MT(2) receptor accommodating the "out-of-plane" substituent of MT(2)-selective antagonists. The acetamide (6b) bearing an usubstituted indoline moiety displayed an excellent binding affinity and selectivity toward the MT(2)-subtype (MT(2), K(i) = 1 nM; MT(1), K(i) = 115 nM), behaving as a competitive antagonist. 5-Me, 5-OMe, 5-Br, 6-NH(2), and 6-NO(2) substitution of the indoline moiety reduced both MT(2) affinity and selectivity, indicating that hydrophobic interactions play a decisive role in binding the out-of-plane substituent. The cyclobutanecarboxamide (6e) showed a biphasic binding pattern at MT(2) receptors, indicating the presence of two MT(2) binding sites, a high affinity (K(i) = 1 pM) and a low affinity (K(i) = 148 nM), while MT(1) binding affinity was very low (K(i) = 1.4 microM). Functional analysis of 6e revealed it to be an antagonist at MT(1) receptors and a partial agonist, at best, at MT(2) receptors.

Knowledge Graph

Similar Paper

2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT<sub>2</sub>-Selective Melatonin Receptor Antagonists
Journal of Medicinal Chemistry 2009.0
2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist
MedChemComm 2011.0
2-N-Acylaminoalkylindoles:  Design and Quantitative Structure−Activity Relationship Studies Leading to MT<sub>2</sub>-Selective Melatonin Antagonists
Journal of Medicinal Chemistry 2001.0
Mapping the Melatonin Receptor. 6. Melatonin Agonists and Antagonists Derived from 6H-Isoindolo[2,1-a]indoles, 5,6-Dihydroindolo[2,1-a]isoquinolines, and 6,7-Dihydro-5H-benzo[c]azepino[2,1-a]indoles
Journal of Medicinal Chemistry 2000.0
Analysis of Structure−Activity Relationships for MT<sub>2</sub> Selective Antagonists by Melatonin MT<sub>1</sub> and MT<sub>2</sub> Receptor Models
Journal of Medicinal Chemistry 2005.0
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands
Bioorganic &amp; Medicinal Chemistry 2009.0
Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands
Bioorganic &amp; Medicinal Chemistry 2008.0
4-Substituted anilides as selective melatonin MT 2 receptor agonists
Bioorganic &amp; Medicinal Chemistry Letters 2004.0
2-[N-Acylamino(C<sub>1</sub>−C<sub>3</sub>)alkyl]indoles as MT<sub>1</sub> Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
Journal of Medicinal Chemistry 1998.0
Design and Synthesis ofN-(3,3-Diphenylpropenyl)alkanamides as a Novel Class of High-Affinity MT<sub>2</sub>-Selective Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2006.0